GlassScriptPhysician profile
Nirav N Desai
NPI 1790911352
$3,615.49
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $583 · 2021: $311 · 2022: $521 · 2023: $923 · 2024: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $806.55 | 2019-2024 | Impella |
| Boston Scientific Corporation | $730.68 | 2019-2024 | Watchman Access System |
| Medtronic, INC. | $571.20 | 2021-2024 | Corevalve Evolut R |
| Abbott Laboratories | $548.32 | 2022-2024 | Portico, Epic, Xience Skypoint |
| Medtronic Vascular, INC. | $279.60 | 2019-2020 | |
| Edwards Lifesciences Corporation | $183.81 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $175.24 | 2019 | |
| Glaxosmithkline, LLC. | $124.78 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $63.74 | 2021-2023 | Lifevest |
| Covidien LP | $55.08 | 2019 | |
| Novo Nordisk INC | $23.09 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.75 | 2022 | |
| Angiodynamics, INC. | $12.57 | 2022 | |
| Biotronik INC. | $11.24 | 2019 | |
| Cvrx, INC. | $10.84 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nirav Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.